- Home
- products
- switzerland
- testing services targeting to preclinical studies
Auris Medical Testing Services Targeting To Preclinical Studies Equipment Supplied In Switzerland
1 equipment items found
Manufactured by:Auris Medical AG based inBasel, SWITZERLAND
AM-125 for the treatment of vertigo is expected to complete its Phase 2 TRAVERS trial in Q2 2022 and to move into Phase 3 in Q4 2022. Keyzilen® (AM-101) for the treatment of acute inner ear tinnitus and Sonsuvi® (AM-111) for the treatment of acute inner ear hearing loss have both been evaluated in Phase 3 trials, but will require further clinical testing. ...